Pliant Therapeutics Inc. (PLRX) Adds David Pyott to Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. ORCL
2. SPY
3. GMAB
4. ACCV
5. FLG
6. META
7. FICO
8. SMMT
9. QQQ
10. SPCX

Go back to Pliant Therapeutics Inc. (PLRX) Adds David Pyott to Board

Pliant Therapeutics Announces Appointment of David Pyott to Board of Directors

January 12, 2021 8:00 AM EST

SOUTH SAN FRANCISCO, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis, today announced the appointment of Dr. David Pyott, former Chairman and Chief Executive Officer of Allergan, to Pliants Board of Directors.  

David is an accomplished international pharmaceutical executive whose extensive experience in building companies will be invaluable at this stage of Pliants development, said Bernard Coulie, M.D., Ph.D., President and Chief Executive Officer... More